Short answer: a new formula usually runs 10 to 16 weeks from approved brief to released batch, and a repeat order on an existing formula runs 3 to 6 weeks. The variable that surprises buyers most is not production — it is the stability and compatibility work that has to finish before bulk can be filled. Everything below separates the stages you control from the ones physics controls.
Most timeline estimates you will read online describe the factory floor. Production is actually the shortest and most predictable part of the schedule. The long pole is the front end: agreeing what the product is, then proving it will still be that product after a season on a shelf.
The stages, and what each one really costs in time
| Stage | Typical duration | What it depends on |
|---|---|---|
| Brief to costed quotation | 24 hours (business days) | How complete your brief is |
| Sample development | 5–14 days | Whether the base already exists |
| Sample approval rounds | 1–3 weeks | Number of revision rounds |
| Stability & compatibility testing | 4–12 weeks | Accelerated vs real-time, pack complexity |
| Bulk manufacture | 10–15 days | Formula type and batch size |
| Filling, QC and release | 3–10 days | Pack format and filling line |
| Documents and shipping | 3–14 days | Destination and transport mode |
Read the table as a sequence with overlaps, not as a queue. Bulk manufacture can sometimes start on an accelerated stability read while the real-time arm continues in parallel — but only where the regulatory regime and the pack allow it, and it is a decision you should make explicitly rather than assume.
Stage one: the brief decides more of the timeline than the factory does
A brief that specifies texture, claim, target market, price point, pack format and order volume will come back costed within 24 hours on business days. A brief that says "a vitamin C serum" comes back with questions, and every round of questions costs days.
The single highest-leverage thing you can do before contacting any manufacturer is to write the brief properly. We cover the exact field structure in what to write in a cosmetics RFQ to get a real quote in 24 hours, and the short version is: the more constraints you fix up front, the fewer revisions you pay for later.
Stage two: sampling is fast — agreeing on the sample is not
Physical samples typically take 5–14 days depending on whether you are building on an existing base or starting from a blank sheet. That part is rarely the bottleneck.
The bottleneck is consensus. A brand with one decision-maker approves a sample in one round. A brand with a founder, a marketing lead and an investor each holding a different view of "rich enough" can spend three weeks and four iterations arriving at the same formula. Budget two rounds in your plan and be pleasantly surprised if you need one.
Stage three: stability testing is the real long pole
This is the stage that turns a six-week project into a four-month one, and it is the stage most buyers discover only after they have promised a launch date to a retailer.
Stability work answers a physical question: will this formula stay within specification over its claimed shelf life, in this specific pack, in the climate it will actually be stored and shipped in? It runs on two tracks.
Accelerated testing holds samples at elevated temperature for a compressed period — commonly around 4 to 12 weeks depending on the protocol — to provoke change early. It gives you an early warning, not the final answer.
Real-time testing holds samples at ambient conditions for the full claimed shelf life. It gives you the actual evidence. A three-year claim needs three years of data to be fully supported, which is why most brands launch on accelerated data plus a documented real-time program that continues after launch.
Compatibility testing is the companion track: formula against pack, pack against formula. A pump that swells, a liner that interacts, a tube coating that migrates — these fail in compatibility, not in the beaker.
Stage four: bulk manufacture is the predictable part
Once the formula is locked and the pack is confirmed, bulk manufacture is the part of the schedule with the least variance: typically 10 to 15 days, driven by batch size, whether the process needs heating and cooling cycles, and how many other products share the line.
This is also where the four release documents are generated — certificate of analysis, stability summary, microbiology report, and MoCRA / CPNP-ready documentation — because they are produced from the actual batch, not from the sample.
Stage five: filling and release are where pack format shows its teeth
Filling a simple bottle is quick. Filling a two-chamber pack, an airless pump, or a hot-pour stick takes longer because the product has to be held at a specific temperature and viscosity to run at all. Expect 3 to 10 days here, and expect the range to be set by the pack, not the formula.
Every batch is compared against the retained Golden Sample before release. That comparison is a gate you want: it is the mechanism that catches a batch that is technically within tolerance but visually off, before it reaches your customer.
The three things that quietly add weeks
1. A pack you have not chosen yet. You cannot do compatibility testing against a pack that does not exist. Every week the packaging decision slips is a week the whole critical path slips, because stability and compatibility sit downstream of it. Choose the pack at the same time you choose the formula, not after.
2. An ingredient that needs documentation you cannot supply. Novel or restricted ingredients may need safety assessment, documentation or market-specific clearance. If the ingredient list is not settled, the compliance work cannot start — and compliance work has its own lead time.
3. A launch date treated as a manufacturing constraint. Factories can move faster on some stages; they cannot make a stability study finish sooner than it finishes. If a retailer has given you a hard date, work backwards from the stability program, not from the production schedule.
How to compress the timeline without cutting corners
- Reuse a proven base. Building a variation on an existing formula removes most of the stability uncertainty because the system has already been characterised.
- Decide the pack early. It unlocks compatibility testing earlier and removes the most common critical-path stall.
- Run testing tracks in parallel, not in series. Microbiology, stability and compatibility can and should overlap.
- Keep one decision-maker. Approval rounds scale with the number of approvers, not the complexity of the formula.
- Prepare documents while production runs. Artwork, labeling and market notifications are your workstream, and they can proceed in parallel with the factory's.
Aligning the timeline with a retail launch
If you have a retail or marketplace deadline, the honest planning order runs backwards from the stability program: real-time study start date → accelerated read date → bulk production → filling → shipping → your own labeling and notification work → shelf date. Build that chain first, then negotiate the deadline against it.
A manufacturer that tells you the timeline is shorter than this is either describing a different product or discounting a risk you will end up carrying.
FAQ
Q: How long does a first order take from brief to delivered product? A: Plan on 10 to 16 weeks for a new formula from approved brief to released batch, plus 3 to 14 days for documents and shipping. A repeat order on an existing formula runs 3 to 6 weeks.
Q: Can bulk production start before stability testing finishes? A: Sometimes — bulk can start on an accelerated stability read while the real-time arm continues in parallel, but only where the regulatory regime and the pack allow it. Treat it as a decision you make explicitly, never as a default.
Q: What single decision delays a project most often? A: A pack you have not chosen yet. Compatibility testing cannot start against a pack that does not exist, and both compatibility and stability sit downstream of that choice, so every week the packaging decision slips, the whole critical path slips.
Q: Why do some brands need four sample rounds? A: Approval rounds scale with the number of approvers, not with the complexity of the formula. Budget two rounds, keep one decision-maker, and write a brief that fixes texture, claim, market, pack and volume up front.
Q: My retailer gave me a hard launch date. Can it be met? A: Work backwards from the stability programme rather than from the production schedule: real-time study start, accelerated read, bulk production, filling, shipping, then your own labelling and notification work. A manufacturer that quotes a shorter chain than this is either describing a different product or discounting a risk you will end up carrying.